San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Qualcomm Predicts Clear Sailing Despite Choppy Waters

We are leading the way to 5G. We’re expanding to more corners of the smartphone. Choppy waters? We’ve sailed through them before.

By Brad Graves April 20, 2017 12:49 p.m.   $$ Share

5 Takeaways From the Man Behind S.D.’s $12B Biotech

Osman Kibar, the founder and CEO of Samumed LLC, shares some of what he's learned about science, medicine and commerce.

By Sarah de Crescenzo April 26, 2017 5:08 p.m. share »

Q1 Earnings Show NuVasive's Strong Financial Position

San Diego medical device maker NuVasive Inc. met Wall Street’s expectations in the first quarter with revenue up 16 percent to $250 million.

By Brittany Meiling April 26, 2017 3:51 p.m. share »

Here’s How Much Illumina’s 5 Highest-Paid Executives Earned

The five highest-paid executives at Illumina Inc. each pulled in over $2 million in compensation last year, with an average of $4 million each.

By Brittany Meiling April 26, 2017 3:11 p.m. share »
Tease photo

Taylor Sandison Named Chief Medical Officer at Cidara Therapeutics

San Diego’s Cidara Therapeutics Inc., a public company developing anti-infective medications, has officially removed the “interim” from its chief medical officer’s title.

By Brittany Meiling April 25, 2017 10:29 a.m. share »
Tease photo

Robert E. Hoffman Named CFO at Heron Therapeutics

Local biotech Heron Therapeutics Inc. has recruited Robert E. Hoffman, a longtime Arena Pharmaceuticals executive, to serve as Heron’s new chief financial officer and senior vice president of finance.

By Brittany Meiling April 24, 2017 3:55 p.m. share »

Arena Pharmaceuticals Raises $79.4M in Common Stock Offering

Local drugmaker Arena Pharmaceuticals has raised $79.4 million in an offering of its common stock, the company announced April 21.

By Brittany Meiling April 21, 2017 2:50 p.m. share »
Tease photo

Scripps Health Sells Former Hospice Property in Hillcrest for $20 Million

San Diego’s Scripps Health has sold a former hospice facility that it owns in Hillcrest to a Houston-based investment company for $20 million. Camden USA Inc. plans to build a multifamily project on the eight-acre property at 4311 Third Ave., according to CoStar Group and public data.

By Lou Hirsh April 20, 2017 4:57 p.m. share »

Mast Merger Vote Faces Delay

Mast Therapeutics Inc., a local public biotech in the process of being acquired by Austin-based Savara Inc., may have to postpone its meeting to vote on the planned merger.

By Brittany Meiling April 20, 2017 4:47 p.m. share »

IriSys' Deal with National Cancer Institute Doubles to $6 Million

Local drugmaker IriSys LLC announced Thursday that its contract with the National Cancer Institute (NCI) has doubled in value from $3 million to $6 million.

By Brittany Meiling April 20, 2017 3:28 p.m. share »

Ionis Pharmaceuticals to Partner With Chinese Biotech

Carlsbad drugmaker Ionis Pharmaceuticals Inc. has inked a deal with a Chinese biotech that will help Ionis develop and sell its medicines in China.

By Brittany Meiling April 19, 2017 4:25 p.m. share »

Tocagen Inc. Raises $97.8 Million in IPO

San Diego drugmaker Tocagen Inc. ended up raising $97.8 million in an upsized initial public offering this week, making it the largest local IPO since Otonomy’s debut in 2014.

By Brittany Meiling April 19, 2017 2:54 p.m. share »

Drugmaker Tocagen to Raise $85 Million in IPO

San Diego drugmaker Tocagen Inc. plans to raise $85 million in an initial public offering, the company announced Thursday.

By Brittany Meiling April 13, 2017 2:57 p.m. share »

Stock Offering Shakes Investors Confidence in Sorrento Therapeutics

Stock is tanking for local drugmaker Sorrento Therapeutics Inc. following news that it intends to raise $47 million in a public stock offering.

By Brittany Meiling April 13, 2017 2:55 p.m. share »
Tease photo

What's Ex-Google Ventures Exec Up To?

Ex-Google Ventures boss Bill Maris considered launching a $230 million health care fund in late 2016, but ultimately thought better of it. What's he up to?

By Sarah de Crescenzo April 13, 2017 2:52 p.m. share »

Execs Given the ‘Keys’ And Cash for Biotech

Investors have handed the reins of an out-of-state biotech company — along with $40 million in fresh capital — to the former C-suite of San Diego’s short-lived Laguna Pharmaceuticals.

By Brittany Meiling April 13, 2017 1:38 p.m. share »